#United States #Los Angeles #securities lawsuit #DJS Law Group #Capricor Therapeutics

Capricor Therapeutics Faces Legal Action for Securities Violations

Capricor Therapeutics, Inc. finds itself in the spotlight due to a class action lawsuit alleging violations of securities laws. The lawsuit, initiated by the DJS Law Group, highlights specific infractions tied to the company's disclosures and clinical trial processes.

The legal challenge emphasizes issues surrounding the company’s handling of its clinical data analysis for its drug Deramiocel, where reported adjustments to the statistical analysis plan were made without the necessary FDA agreement prior to its Biologics License Application resubmission. Such actions, according to the lawsuit, resulted in misleading statements that could have influenced investors’ decisions during the class period from December 17, 2025, to July 26, 2026.

Class Action Details

The case is centered around allegations that Capricor misled the market by providing false information regarding its clinical trial results and FDA approval processes. Investors who purchased CAPR shares during the stated period may qualify for restitution, encouraging those affected to reach out to the DJS Law Group for participation as potential lead plaintiffs. Notably, serving as a lead plaintiff is not mandatory for those looking to recover losses.

Important Deadlines

The deadline for individuals to join the case and seek damages is September 28, 2026. A special focus on ensuring that shareholders who felt the brunt of misleading information are compensated is being highlighted by DJS Law Group, underscoring the importance of investor rights in such contexts.

Why Choose DJS Law Group?

DJS Law Group prides itself on advocating for investors through comprehensive support and litigation strategies. With a focus that includes securities class actions and corporate governance disputes, they represent key players in the hedge fund and asset management arenas. Their reputation reflects an unwavering commitment to maximizing returns for clients amidst legal battles.

Call to Action

Shareholders who suffered financial losses due to Capricor's alleged misconduct are urged to act promptly, as important deadlines are approaching. The DJS Law Group emphasizes the urgency of gathering evidence and testimonials to bolster the class action’s effectiveness against Capricor.

Through collaboration and diligent advocacy, the goal remains clear: seeking justice for investors affected by securities violations.

For those interested in joining the legal action or obtaining more information about their rights, contacting the DJS Law Group is highly recommended. With their specialized expertise, they aim to navigate the complexities of securities law on behalf of investors.